ROYAL BANK OF CANADA - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422LAA5. A total of 7 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,710,000
-55.5%
2,000,0000.0%0.00%
-100.0%
Q4 2022$3,843,0002,000,0000.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 7,450,000$13,103,0000.84%
683 Capital Management, LLC 8,100,000$14,094,0000.67%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 18,000,000$31,658,0000.63%
Saltoro Capital, LP 250,000$439,0000.22%
UBS OCONNOR LLC 2,000,000$3,461,000,0000.07%
LAZARD ASSET MANAGEMENT LLC 7,875,000$13,836,0000.02%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 4,000,000$6,948,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders